Picture of Adalta logo

1AD — Adalta News Story

0.000.00%
au flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Adalta Says FDA Assigns Orphan Drug Designation For EW-001 In Mesothelioma To Adalta

BRIEF-Adalta Says FDA Assigns Orphan Drug Designation For EW-001 In Mesothelioma To Adalta

- Adalta Ltd 1AD.AX:

  • FDA ASSIGNS ORPHAN DRUG DESIGNATION FOR EW-001 IN MESOTHELIOMA TO ADALTA

Further company coverage: 1AD.AX


((Reuters.Briefs@thomsonreuters.com;))

Recent news on Adalta

See all news